Condition: Endometrioma · Infertility · Sclerotherapy · Sponsor: Ankara University
The goal of this randomized controlled trial is to assess the impact of ethanol sclerotherapy on ART cycle outcomes. The main questions it aims to answer are: 1. Does ethanol sclerotherapy before ART cycle has any impact on cumulative live birth rate in patients with endometrioma? 2. Does ethanol sclerotherapy improve chronic pelvic pain, dysmenorrhea, complications during oocyte retrieval, response to ovarian stimulation (number of mature oocytes retrieved), and pregnancy loss rates? Infertile patients with endometrioma between 4-10 cm who are scheduled for ART within 2 cycles will be randomized to ethanol sclerotherapy or no intervention.
This description comes directly from the study's public registry record.
Yavuz Emre Sukur · +905332409381 · yesukur@gmail.com
Sezcan Mumusoglu · +905326404673 · sezcanmumusoglu@gmail.com
Always discuss trial participation with your own doctor first.
| Başkent University Adana IVF Center | Adana, Turkey (Türkiye) | Recruiting |
| Ankara University School of Medicine, Department of Obstetrics and Gynecology | Ankara, Turkey (Türkiye) | Recruiting |
| Bahçeci IVF Clinic | Istanbul, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05962775